Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Status:
Recruiting
Trial end date:
2025-06-22
Target enrollment:
Participant gender:
Summary
This is an open, single-arm, prospective，clinical study to evaluate efficacy and safety of
Auto CAR-T cell injection in the treatment of recurrent or refractory Hematopoietic and
Lymphoid Tissue Tumors in Children